These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10336331)

  • 1. C(Tr)/C(Cr) ratio in pancreatic disease.
    Malesci A; Bonato C; Bersani M
    Gastroenterology; 1982 Mar; 82(3):603. PubMed ID: 10336331
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of trypsin/creatinine clearance ratio in the differential diagnosis of chronic pancreatic disease.
    Farini R; Fabris C; del Favero G; Bonvicini P; de' Best T; Piccoli A; Baccaglini U; Plebani M; Pedrazzoli S; Kind R; Ceriotti G; Naccarato R
    Gastroenterology; 1981 Aug; 81(2):242-6. PubMed ID: 6165644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal involvement in chronic pancreatic disease: effects on trypsin and amylase plasma-urine transfer.
    Fabris C; Basso D; Del Favero G; Benini L; Angonese C; Piccoli A; Plebani M; Burlina A; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S59-65. PubMed ID: 2463319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypsin clearance and pancreatic disease.
    Rashid SA; Cooper EM; Playforth MJ; McMahon MJ
    Lancet; 1980 Feb; 1(8164):363-4. PubMed ID: 6153447
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary immunoreactive trypsin in pancreatic cancer.
    Andriulli A; Masoero G
    Lancet; 1980 Jan; 1(8159):93. PubMed ID: 6101436
    [No Abstract]   [Full Text] [Related]  

  • 7. Trypsin and elastase-1 in chronic pancreatic diseases.
    Vantini I; Benini L; Vaona B
    Int J Pancreatol; 1988; 3 Suppl 1():S53-7. PubMed ID: 3062101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].
    Clavé P; Boadas J; González-Carro P; Mora J; Pérez C; Martínez A; Roca M; Lluís F; Farré A
    Gastroenterol Hepatol; 1999; 22(7):335-41. PubMed ID: 10535205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.
    Allen HS; Steiner J; Broussard J; Mansfield C; Williams DA; Jones B
    Can J Vet Res; 2006 Oct; 70(4):313-6. PubMed ID: 17042387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon?
    Dreiling DA; Leichtling JJ; Janowitz HD
    Am J Gastroenterol; 1974 Apr; 61(4):290-6. PubMed ID: 4831310
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum prostate-specific antigen in pancreatic disease.
    Pezzilli R; Bertaccini A; Billi P; Zanarini L; Miglio F; Martorana G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):580-3. PubMed ID: 10604096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis.
    Ruszniewski P; Malka D; Hammel P; Maire F; Rufat P; Madeira I; Pessione F; Lévy P
    Gut; 2004 May; 53(5):771. PubMed ID: 15082603
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary immunoreactive trypsin excretion: a non-invasive screening test for pancreatic cancer.
    Lake-Bakaar G; McKavanagh S; Summerfield JA
    Lancet; 1979 Oct; 2(8148):878-80. PubMed ID: 90969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid urinary trypsinogen-2 test in the early diagnosis of acute pancreatitis: a meta-analysis.
    Chang K; Lu W; Zhang K; Jia S; Li F; Wang F; Deng S; Chen M
    Clin Biochem; 2012 Sep; 45(13-14):1051-6. PubMed ID: 22575591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of serum levels of trypsin in the diagnosis of pancreatic diseases].
    Wacheck W
    Ric Clin Lab; 1983; 13 Suppl 2():119-24. PubMed ID: 6199827
    [No Abstract]   [Full Text] [Related]  

  • 16. The use and mechanism of urinary clearance of cathodic trypsin-like immunoreactivity to creatinine clearance ratio in the diagnosis of pancreatic cancer.
    Møller-Petersen J; Smidt-Jensen S
    Clin Chim Acta; 1983 May; 130(2):163-70. PubMed ID: 6347435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour.
    Teich N; Kleeff J; Lochs H; Mössner J; Keim V; Friess H; Ockenga J
    BMC Gastroenterol; 2005 Jun; 5():20. PubMed ID: 15969757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic elastase 1].
    Ogawa M
    Rinsho Byori; 2001 Nov; Suppl 116():131-4. PubMed ID: 11797373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular diagnosis in pancreatic carcinoma].
    Dítĕ P; Lukás Z; Hermanová M; Kroupová I; Kleibl Z; Brázdil J; Pazourková M; Novotný Z; Růzicka M
    Vnitr Lek; 2003 Jul; 49(7):559-62. PubMed ID: 12931440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pancreatic cancer or chronic pancreatitis?].
    Berthélemy P; Pariente A
    Gastroenterol Clin Biol; 1998 Feb; 22(2):149-51. PubMed ID: 9762188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.